Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease
ConclusionsThe Japanese public intractable disease support system contributes to improvement of ADPKD treatment.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Chronic Kidney Disease | Databases & Libraries | Japan Health | Men | Polycystic Kidney Disease | Study | Urology & Nephrology